A. C. Roehl

Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type‐3 NF1 deletions

Antje M Zickler, H. Kestler, D. Cooper, 2012, Human mutation.

Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type‐2 NF1 deletions

D. Cooper, J. Högel, H. Kehrer-Sawatzki, 2010, Human mutation.

Extended runs of homozygosity at 17q11.2: an association with type‐2 NF1 deletions?

D. Cooper, J. Högel, H. Kehrer-Sawatzki, 2010, Human mutation.

Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports

D. Cooper, M. Schuhmann, H. Kehrer-Sawatzki, 2011, Journal of medical case reports.

Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions

D. Cooper, J. Högel, H. Kehrer-Sawatzki, 2010, Journal of Medical Genetics.

Tissue‐specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/−) stem cells

D. Cooper, J. Högel, H. Kehrer-Sawatzki, 2012, Human mutation.